Anhui Wanwei Updated High-Tech Material Industry (600063.SH) intends to transfer asset assets related to PVA water-soluble film project equipment to its subsidiary.
Wanwei High-tech (600063.SH) announced that the company plans to transfer the equipment assets related to the PVA water-soluble film project (excluding blown film related equipment) to its holding subsidiary Anhui Wanwei Degradable Film Materials Co., Ltd. (referred to as "Degradable Film Materials Company"). Based on the assessed market value, the book value of the target assets is 19.8432 million yuan, the assessed value is 20.8598 million yuan, and the assessment appreciation rate is 5.12%.
Anhui Wanwei Updated High-Tech Material Industry (600063.SH) announced that the company plans to transfer the equipment assets (excluding film blowing equipment) related to the PVA water-soluble film project to its subsidiary Anhui Wanwei Degradable Film Material Co., Ltd. (referred to as "Degradable Film Material Company"). Based on the assessed market value, the book value of the target assets is 19.8432 million yuan, the assessed value is 20.8598 million yuan, and the appreciation rate is 5.12%.
This transaction is beneficial for the company to focus on the development of new materials, clarify the management rights and responsibilities of parent and subsidiary companies, integrate similar businesses, eliminate industry competition, help subsidiary companies expand and improve their capabilities, accelerate the scale of new material business, and further strengthen the company's competitive position in the polyvinyl alcohol (PVA) water-soluble film industry. The equipment being transferred in this transaction is in good condition, complete with all necessary accessories, and has the capability for continuous production operation, which will help the Degradable Film Material Company quickly release the production capacity of water-soluble film products and enhance the market share and profitability of the company's new material products.
Related Articles
.png)
LIVZON PHARMA (01513): The application for market approval of Lecanikta monoclonal antibody injection has been accepted by the National Medical Products Administration.

Yuanheng Gas (00332) plans to carry out a share capital restructuring.

HUANENG POWER (00902) A-share trading abnormal fluctuations do not exist major issues that should be disclosed but have not been disclosed.
LIVZON PHARMA (01513): The application for market approval of Lecanikta monoclonal antibody injection has been accepted by the National Medical Products Administration.
.png)
Yuanheng Gas (00332) plans to carry out a share capital restructuring.

HUANENG POWER (00902) A-share trading abnormal fluctuations do not exist major issues that should be disclosed but have not been disclosed.






